OBI Pharma, Inc. (4174) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

OBI Pharma, Inc. (4174) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

OBI Pharma, Inc. (4174) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
OBI Pharma, Inc. (4174) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 22, 2016
24 pages — Published Sep 22, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

OBI Pharma, Inc. (OBI Pharma) is a biotechnology company that focuses on the development of therapies for the treatment of cancer and infectious diseases. The company develops its pipeline products through its carbohydrate synthesis discovery platform. Its flagship product under development includes OBI-822, an active immunotherapy which is intended for the treatment of metastatic breast cancer. OBI also focuses on the development of active immunotherapies intended for the treatment of various cancers including lung, prostate, pancreatic, stomach, and ovarian.

OBI Pharma, Inc. (4174) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal ration

  
Source:
Document ID
GDPH429535D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
OBI Pharma, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
OBI Pharma, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
OBI Pharma, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
OBI Pharma, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
OBI Pharma, Inc., Medical Devices Deals, 2010 to YTD 201691
OBI Pharma, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
OBI Pharma, Inc., Pharmaceuticals &Healthcare, Deal Details1110
  Venture Financing111
    Optimer Biotech Raises US$18.3 Million In Financing111
    Optimer Biotech Raises US$15.5 Million In Financing121
  Partnerships131
    Merck Enters into Agreement with OBI Pharma131
  Licensing Agreements141
    Optimer Biotech Terminates Licensing Agreement With Scripps Research Institute For OPT-88141
    OBI Pharma Enters into Licensing Agreement with Academia Sinica151
  Equity Offering161
    OBI Pharma Raises USD51 Million through Issue of Shares161
  Acquisition171
    Taiwanese Investor Consortium Completes First Tranche Acquisition Of Remaining 43.5% Stake In Optimer Biotech172
    Optimer Pharma Acquires 0.7% Stake In Optimer Biotech For US$0.5 Million191
    Optimer Pharma Sells Minority Stake In Optimer Biotech201
OBI Pharma, Inc. - Key Competitors211
Key Employees221
Locations And Subsidiaries231
  Head Office231
  Other Locations &Subsidiaries231
Appendix241
  Methodology241
  About GlobalData241
  Contact Us241
  Disclaimer241

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "OBI Pharma, Inc. (4174) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 22, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/OBI-Pharma-Inc-4174-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-25110>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). OBI Pharma, Inc. (4174) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 22, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/OBI-Pharma-Inc-4174-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-25110>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research